Back
OncoCyte Quote, Financials, Valuation and Earnings
Sponsored
OCX
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
46
OCX
OncoCyte
Last Price:
2.93
Seasonality Move:
46.75%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.OncoCyte Price Quote
$2.93
+0.03 (+1.03%)
(Updated: November 12, 2024 at 5:55 PM ET)
OncoCyte Key Stats
Sell
46
OncoCyte (OCX)
is a Sell
Day range:
$2.79 - $2.95
52-week range:
$2.29 - $4.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
26.69
P/B ratio:
2.15%
Volume:
24.8K
Avg. volume:
27.2K
1-year change:
4.32%
Market cap:
$48.8M
Revenue:
$1.5M
EPS:
$-4.37
How Much Does OncoCyte Make?
Is OncoCyte Growing As A Company?
OncoCyte Stock Price Performance
What Is OncoCyte 52-Week High & Low?
OncoCyte Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy OncoCyte?
Is OncoCyte Cash Flow Positive?
OncoCyte Return On Invested Capital
OncoCyte Earnings Date & Stock Price
-
What Is OncoCyte's Stock Price Today?
A single share of OCX can be purchased today for 2.90 -
What Is OncoCyte’s Stock Symbol?
OncoCyte trades on the nasdaq under the ticker symbol: OCX -
When Is OncoCyte’s Next Earnings Date?
The next quarterly earnings date for OncoCyte is scheduled on November 12, 2024 -
When Is OCX's next ex-dividend date?
OncoCyte's next ex-dividend date is November 13, 2024 -
How To Buy OncoCyte Stock?
You can buy OncoCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
OncoCyte Competitors
OncoCyte Dividend Yield
-
What Is OCX Dividend Yield?
OncoCyte’s dividend yield currently is 0% -
What Is OncoCyte’s Payout Ratio?
OncoCyte’s payout ratio is 0% -
When Did OncoCyte Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is OncoCyte’s Dividend Per Share?
OncoCyte pays a dividend of $0.00 per share
OncoCyte Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -16.76% |
Revenue: | -77.54% | -66.71% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 4.13 |
Upside from Last Price: | 42.24% |